Rx only · Injection, Solution · Intradermal

Tuberculin Purified Protein Derivative

Brands: Tubersol · Tuberculin Purified Protein Derivative

2 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US3 NDCs
2 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATC—

RxCUI (US)8948

US makers2 labelers

Packages4

DEA / ScheduleNone

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
Sanofi Vaccines US Inc.	unknown	2	SUPPLYING
A-S Medication Solutions	unknown	2	SUPPLYING

Shortages, recalls, and registration changes attached to this drug concept.

Mar 15, 2021
RECALLRecall (Class II): Tuberculin Purified Protein Derivative (Mantous) TUBERSOL, Stabilized Solution 5 US Units, Rx Only Sanofi Pasteur Limit…
CGMP Deviations: Intermittent exposure to temperature excursion during storage. — Recalling firm: Cardinal Health Inc. — FL, GA, SC